Ovarian Neoplasm ; Psychological Distress
Conditions
Keywords
Ovarian Neoplasms, Psychological Distress, Acceptand and Commitment Therapy (ACT), Nursing intervention
Brief summary
The purpose of this study is to evaluate the feasiblity and effectiveness of an Acceptance and Commitment Therapy (ACT)-based nursing intervention aimed at managing psychological flexibility, distress, anxiety, depression, fear of cancer recurrence/progression, quality of life, and symptoms. Patients will participate in a single online session with a nurse, followed by a daily self-monitoring survey online for one week. Data will be collected at baseline (prior to the ACT session), on day 8 (after one week of self-monitoring), and at 5 weeks. Primary outcome is psychological flexibility.
Detailed description
This study is a preliminary single-group pre-post design aimed at developing and evaluating the feasibility of an ACT-based nursing intervention for distress management in patients with ovarian cancer. A total of 25 ovarian cancer patients who consent to participate will be enrolled in the study. Paticipants will receive a one-time ACT-based nursing intervention lasting approximately 60 minutes. The researcher will coordinate schedules with participants to deliver the ACT-based nursing intervention using Zoom, a video conferencing platform which minimizes time and location constraints. Before the intervention, the research will ensure that the participants' video conferencing is working properly to minimize potential difficulties during the session. Following the single-session intervention, the researcher will send a daily Google Form link to participants for seven consecutive days. Participants will be encouraged to access the link and complete self-monitoring surveys to reinforce the key components addressed in the program.
Interventions
ACT-based nursing intervention is a 1:1 single online session with a nurse, which takes about 60 minutes followed by a daily self-monitoring survey for one week, which encourages patients to practice ACT.
Sponsors
Study design
Eligibility
Inclusion criteria
* adult (19 ≤ age ≤ 75). * ovarian cancer patients with FIGO stage 2-3. * Those who have completed first-line chemotherapy for ovarian cancer (excluding maintenance therapy) within the past 2 years.
Exclusion criteria
* Patients with cognitive problems such as dementia or psychiatric problems such as major depression or generalized anxiety, or who are actively receiving treatment for any of these conditions. * Patients with history of cancer recurrence.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline psychological distress on the last day of self-monitoring (Day 8) | Psychological distress will be assessed at baseline and on the last day of self-monitoring (Day 8). | Psychological distress measured by Distress Thermometer. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from anxiety | within 3 weeks after the last day of self-monitoring (window: 7 days) | Anxiety by the Hospital Anxiety and Depression Scale (HADS). |
| Change from fear of cancer recurrence | within 3 weeks after the last day of self-monitoring (window: 7 days) | Fear of cancer recurrence measured by the Fear of Cancer Recurrence Index (FCRI). |
| Change from baseline depression | within 3 weeks after the last day of self-monitoring (window: 7 days) | depression measured by the Hospital Anxiety and Depression Scale (HADS). |
| Change from quality of life | within 3 weeks after the last day of self-monitoring (window: 7 days) | Quality of life measured by the ECORTC QLQ C-30. |
| Change from symptoms | within 3 weeks after the last day of self-monitoring (window: 7 days) | Symptoms measured by the EORTC QLQ-OV28. |
| Change from psychological flexibility | within 3 weeks after the last day of self-monitoring (window: 7 days) | Psychological flexibility measured by the Acceptance and Action Questionnaire-II (AAQ-II). |